FOMO/Hyping on twitter

vTv Therapeutics to Present Additional Clinical Data from the STEADFAST Study of Azeliragon at the Virtual Alzheimer's Association International Conference


FOMO/Hyping on twitter:

-Moneyline Mark@MoneylineMark
Adding $VTVT swing hold $2.86

-PJ Matlock@PJ_Matlock
$VTVT should be a good one tomorrow on this too

-TexMex@TraderTexMex

$VTVT heating up here

Presenting additional data from STEADFAST study on Tuesday at 6pm est. Alzheimer's data trial update. Traders love forward looking catalysts with tight timeline

-Hugh_Henne (Not Hef)@Hugh_Henne
$VTVT like the consolidation.
Alzheimer’s is always a huge deal...
Over $3 should squeeze

-Zack Morris@MrZackMorris
$VTVT Long on this dip and will swing overnight.